Erasca
Price & Volume
Stats
See more52W Range | $1.04-$3.45 |
Market Cap | $356.9M |
Shares Short | 33M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.69 |
News
See moreYahoo Finance • 9 days ago
Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting
Yahoo Finance • 14 days ago
Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results
Yahoo Finance • 2 months ago
Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference
Yahoo Finance • last year
Erasca Achieves Key Milestones for Naporafenib and ERAS-801 Programs and Extends Cash Runway
About
CEO | Dr. Jonathan E. Lim M.D. |
CFO | Dr. David M. Chacko M.D. |
Address | 3115 Merryfield Row, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 103 |
